Literature DB >> 18008034

The impact of visceral fat in nonalcoholic fatty liver disease: cross-sectional and longitudinal studies.

Masahiko Koda1, Manri Kawakami, Yoshikazu Murawaki, Miho Senda.   

Abstract

BACKGROUND: Nonalcoholic fatty liver disease is increasing worldwide, and attention is being paid to its association with obesity and metabolic syndrome. The aim of this study was to elucidate the role of visceral fat accumulation in hepatic steatosis by cross-sectional and longitudinal studies.
METHODS: We enrolled 125 patients in a cross-sectional study and 28 patients in a longitudinal study and examined visceral and subcutaneous fat thickness, hepatic steatosis score, and biochemical parameters. In the longitudinal study, the influence of weight change on fat distribution and hepatic steatosis was investigated.
RESULTS: In the cross-sectional study, the severity of hepatic steatosis showed a significant positive correlation with body mass index, visceral fat thickness, serum albumin, alanine aminotransferase (ALT), cholinesterase, fasting insulin, and the homeostasis model assessment of insulin resistance. ALT, visceral fat thickness, and serum albumin were independent factors for hepatic steatosis. In the longitudinal study, visceral fat thickness fluctuated closely with changes in body weight, and had the strongest relationship with the change of hepatic steatosis by multivariate analysis.
CONCLUSIONS: Visceral fat was the most important factor for the development of hepatic steatosis. Visceral fat thickness can be measured by sonography easily, noninvasively, and repeatedly for assessment of central obesity and monitoring of the efficacy of treatment of nonalcoholic fatty liver disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18008034     DOI: 10.1007/s00535-007-2107-z

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  23 in total

Review 1.  Is weight reduction an effective therapy for nonalcoholic fatty liver? A systematic review.

Authors:  Rex T Wang; Ronald L Koretz; Hal F Yee
Journal:  Am J Med       Date:  2003-11       Impact factor: 4.965

2.  Body fat distribution, relative weight, and liver enzyme levels: a population-based study.

Authors:  Saverio Stranges; Joan M Dorn; Paola Muti; Jo L Freudenheim; Eduardo Farinaro; Marcia Russell; Thomas H Nochajski; Maurizio Trevisan
Journal:  Hepatology       Date:  2004-03       Impact factor: 17.425

3.  Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease.

Authors:  Ayako Suzuki; Keith Lindor; Jenny St Saver; James Lymp; Flavia Mendes; Ayako Muto; Toshihide Okada; Paul Angulo
Journal:  J Hepatol       Date:  2005-07-11       Impact factor: 25.083

4.  Sonographic subcutaneous and visceral fat indices represent the distribution of body fat volume.

Authors:  Masahiko Koda; Miho Senda; Masayuki Kamba; Koji Kimura; Yoshikazu Murawaki
Journal:  Abdom Imaging       Date:  2006-09-01

5.  Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease.

Authors:  Yuichiro Eguchi; Takahisa Eguchi; Toshihiko Mizuta; Yasushi Ide; Tsutomu Yasutake; Ryuichi Iwakiri; Akitaka Hisatomi; Iwata Ozaki; Kyousuke Yamamoto; Yoichiro Kitajima; Yasunori Kawaguchi; Shigetaka Kuroki; Naofumi Ono
Journal:  J Gastroenterol       Date:  2006-05       Impact factor: 7.527

6.  Surgical removal of visceral fat reverses hepatic insulin resistance.

Authors:  N Barzilai; L She; B Q Liu; P Vuguin; P Cohen; J Wang; L Rossetti
Journal:  Diabetes       Date:  1999-01       Impact factor: 9.461

7.  Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

Authors:  P Angulo; J C Keach; K P Batts; K D Lindor
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

Review 8.  Review: The role of insulin resistance in nonalcoholic fatty liver disease.

Authors:  Kristina M Utzschneider; Steven E Kahn
Journal:  J Clin Endocrinol Metab       Date:  2006-09-12       Impact factor: 5.958

9.  Body mass index as a predictor of hepatic steatosis in living liver donors.

Authors:  M E Rinella; E Alonso; S Rao; P Whitington; J Fryer; M Abecassis; R Superina; S L Flamm; A T Blei
Journal:  Liver Transpl       Date:  2001-05       Impact factor: 5.799

10.  Validation of tetrapolar bioelectrical impedance method to assess human body composition.

Authors:  H C Lukaski; W W Bolonchuk; C B Hall; W A Siders
Journal:  J Appl Physiol (1985)       Date:  1986-04
View more
  25 in total

1.  Usefulness of differentiating metabolic syndrome into visceral fat type and subcutaneous fat type using ultrasonography in Japanese males.

Authors:  Masahiro Sogabe; Toshiya Okahisa; Shingo Hibino; Akira Yamanoi
Journal:  J Gastroenterol       Date:  2011-11-09       Impact factor: 7.527

2.  Fatty liver, abdominal visceral fat, and cardiometabolic risk factors: the Jackson Heart Study.

Authors:  Jiankang Liu; Caroline S Fox; DeMarc Hickson; Aurelian Bidulescu; J Jeffery Carr; Herman A Taylor
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

Review 3.  What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?

Authors:  Carmine Finelli; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

4.  Effects of canagliflozin, an SGLT2 inhibitor, on hepatic function in Japanese patients with type 2 diabetes mellitus: pooled and subgroup analyses of clinical trials.

Authors:  Yuya Seko; Yoshio Sumida; Kazuyo Sasaki; Yoshito Itoh; Hiroaki Iijima; Toshio Hashimoto; Shinichi Ishii; Nobuya Inagaki
Journal:  J Gastroenterol       Date:  2017-07-01       Impact factor: 7.527

5.  Inhibition of adipose tissue PPARγ prevents increased adipocyte expansion after lipectomy and exacerbates a glucose-intolerant phenotype.

Authors:  A D Booth; A M Magnuson; K A Cox-York; Y Wei; D Wang; M J Pagliassotti; M T Foster
Journal:  Cell Prolif       Date:  2016-12-15       Impact factor: 6.831

6.  Hybrid training of voluntary and electrical muscle contractions reduces steatosis, insulin resistance, and IL-6 levels in patients with NAFLD: a pilot study.

Authors:  Takumi Kawaguchi; Naoto Shiba; Takashi Maeda; Toru Matsugaki; Yoshio Takano; Minoru Itou; Masahiro Sakata; Eitaro Taniguchi; Kensei Nagata; Michio Sata
Journal:  J Gastroenterol       Date:  2011-02-22       Impact factor: 7.527

7.  Strong and persistent effect on liver fat with a Paleolithic diet during a two-year intervention.

Authors:  J Otten; C Mellberg; M Ryberg; S Sandberg; J Kullberg; B Lindahl; C Larsson; J Hauksson; T Olsson
Journal:  Int J Obes (Lond)       Date:  2016-01-20       Impact factor: 5.095

8.  Trunk fat as a determinant of liver disease.

Authors:  Jacquelyn J Maher
Journal:  Gastroenterology       Date:  2010-02-23       Impact factor: 22.682

9.  Combination of conjugated linoleic acid with fish oil prevents age-associated bone marrow adiposity in C57Bl/6J mice.

Authors:  Ganesh V Halade; Md M Rahman; Paul J Williams; Gabriel Fernandes
Journal:  J Nutr Biochem       Date:  2010-07-24       Impact factor: 6.048

10.  Ethnic differences in hepatic steatosis: an insulin resistance paradox?

Authors:  Richard Guerrero; Gloria L Vega; Scott M Grundy; Jeffrey D Browning
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.